FDA Approves Alli(TM) (orlistat 60 Mg Capsules) Over-The-Counter GlaxoSmithKline Consumer Healthcare announces today that the U.S. Food and Drug Administration (FDA) approved the weight-loss product ...
LEXINGTON, Ky. (Oct. 18, 2005) − A 60 mg low-dose version of the prescription weight-loss medication orlistat (marketed by GlaxoSmithKline as Xenical® 120 mg) was found to be safe, effective and ...
September 22, 2011 (London, United Kingdom) — The European Medicines Agency (EMA) says that it has started a review of orlistat-containing medicines to determine whether the "very rare cases of ...
GlaxoSmithKline's First Nonprescription Diet Drug Alli Wins FDA Approval PITTSBURGH, Feb. 7 -- GlaxoSmithKline Consumer Healthcare announces today that the U.S. Food and Drug Administration (FDA) ...
Hong Kong (January 28, 2010) -- New studies show that overweight and obese people using alli® (orlistat 60 mg) with a reduced calorie, lower-fat diet can significantly reduce weight, visceral fat, and ...
[05-26-2010] The U.S. Food and Drug Administration (FDA) has approved a revised label for Xenical to include new safety information about cases of severe liver injury that have been reported rarely ...
Please provide your email address to receive an email when new articles are posted on . The review includes the prescription-only Xenical (orlistat 120 mg, Roche) and the over-the-counter Alli ...
The Annals of Pharmacotherapy. 2007;41(9):1445-1455. Fifteen patients completed 6 months of therapy [50]; again, reductions in weight and waist circumference achieved statistical significance based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results